NN

Neeraja Nagarajan

Active Director Director DIN 11716150
DIN 11716150 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Neeraja Nagarajan

Neeraja Nagarajan is a Director at 7 Med (South) Private Limited (since 2026).

DIN 11716150
Primary Designation Director
First Appointment 03 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
7 Med (South) Private Limited U86100TN2026PTC196244
Director03 Aug 20262026Active

Board colleagues of Neeraja Nagarajan

NameDINCompanyDesignation
Mayank Sharma068418587 Med (South) Private LimitedDirector
Thiagarajan064833157 Med (South) Private LimitedDirector
Vikas Verma063646587 Med (South) Private LimitedNon- Individual Subscriber

Directorship timeline

Open interactive timeline →
7 Med (South) Private Limited
Premium access

Shareholding and investment profile for Neeraja Nagarajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraja Nagarajan

Neeraja Nagarajan currently holds 1 directorship: 7 Med (South) Private Limited (Director, since 03 Aug 2026).

Neeraja Nagarajan was first appointed on 03 Aug 2026 as Director at 7 Med (South) Private Limited.

The current boards of Neeraja Nagarajan's companies include Mayank Sharma (7 Med (South) Private Limited), Thiagarajan (7 Med (South) Private Limited), Vikas Verma (7 Med (South) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available